Literature DB >> 6536839

Interactions of magnesium and potassium in the pathogenesis of cardiovascular disease.

J P Sheehan, M S Seelig.   

Abstract

The interactions of Mg and K in cardiovascular disease are diverse and complex. However, Mg deficiency and loss from the heart and arteries, caused e.g. by dietary deficiency or imbalance, or by diseases and their treatment, can contribute to cardiovascular damage, and to functional abnormalities. Although Mg deficiency interferes with K retention, it is seldom measured in routine clinical practice, and the need to correct low Mg levels, in order to replete K, is rarely considered. The heart, with its high metabolic activity, is particularly vulnerable to Mg deficiency or loss because of the importance of Mg in mitochondrial structure and enzymatic function. The need for Mg to activate Na/K ATPase has long been known. Mg has also been shown to be structurally part of the enzyme in cardiac mitochondria. Additionally, Na/K exchange occurs in association with phosphorylation and dephosphorylation, reactions that are also Mg-dependent. The demonstration that Mg modulates K+/proton (H+) exchange, and that cation selectivity in Na+ and K+ exchange for H+ is highly dependent on the concentration of Mg++, provides new insights into how Mg protects against K loss. The loss of myocardial K that results from Mg deficiency contributes to electrophysiologic changes, as can the Ca shifts of Mg loss. A high Ca/Mg ratio also predisposes to arterial spasms, and increases catecholamine release. Thus the arrhythmogenic potential of Mg deficiency can be related to imbalances between Mg and K or between Mg and Ca, or both. Electrical or K-induced catecholamine release is increased by a low Mg/Ca ratio, as are increased fatty acids and lipids and intravascular hypercoagulability. K or Ca loading of the patient with undiagnosed Mg inadequacy is not only often unsuccessful, but it may carry inherent risks. It can intensify the Mg depletion, the arterial contractility, and ECG abnormality. In the patient receiving digitalis, Mg deficiency can increase drug toxicity. In the case of myocardial infarction, Mg deficiency can increase the risk of malignant ventricular arrhythmias and sudden cardiac death. In the absence of alcoholism or gastrointestinal disease, the use of loop diuretic therapy for congestive heart failure, especially in elderly patients, is the most common cause of Mg depletion. A high concurrence of hypomagnesemia with hypokalemia, from whatever cause, has been documented. However, systemic Mg deficiency can exist despite normal Mg serum levels. Methodological difficulties hamper direct detection of cellular Mg deficiency, but patients can be indirectly evaluated by use of Mg-loading tests, which may be of combined diagnostic and therapeutic value.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6536839

Source DB:  PubMed          Journal:  Magnesium        ISSN: 0252-1156


  13 in total

Review 1.  Drug-induced hypomagnesaemia : scope and management.

Authors:  Jacob Atsmon; Eran Dolev
Journal:  Drug Saf       Date:  2005       Impact factor: 5.606

Review 2.  Role of magnesium sulfate in seizure prevention in patients with eclampsia and pre-eclampsia.

Authors:  J Anthony; R B Johanson; L Duley
Journal:  Drug Saf       Date:  1996-09       Impact factor: 5.606

Review 3.  Sleep Disordered Breathing and the Pathogenesis of Atrial Fibrillation.

Authors:  Thomas Bitter; Dieter Horstkotte; Olaf Oldenburg
Journal:  J Atr Fibrillation       Date:  2013-06-30

Review 4.  [Association of sleep-disordered breathing and malignant arrhythmias in patients with ischemic and dilated cardiomyopathy].

Authors:  Hazem Omran; Thomas Bitter; Henrik Fox; Dieter Horstkotte; Olaf Oldenburg
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2015-03-03

5.  Cation dyshomeostasis and cardiomyocyte necrosis: the Fleckenstein hypothesis revisited.

Authors:  Brian J Borkowski; Yaser Cheema; Atta U Shahbaz; Syamal K Bhattacharya; Karl T Weber
Journal:  Eur Heart J       Date:  2011-03-12       Impact factor: 29.983

6.  [Sleep-disordered breathing and cardiac arrhythmias].

Authors:  T Bitter; B Körber; D Horstkotte; O Oldenburg
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2012-03

7.  Potassium Homeostasis, Oxidative Stress, and Human Disease.

Authors:  Udensi K Udensi; Paul B Tchounwou
Journal:  Int J Clin Exp Physiol       Date:  2017

8.  Myocardial contractility and ischaemia in the isolated perfused rat heart with propofol and thiopentone.

Authors:  B P Kavanagh; M P Ryan; A J Cunningham
Journal:  Can J Anaesth       Date:  1991-07       Impact factor: 5.063

9.  The prospect of serum magnesium and an electrolyte panel as an adjuvant cardiac biomarker in the management of acute myocardial infarction.

Authors:  Ramesh Ramasamy; Sathish Babu Murugaiyan; Niranjan Gopal; Rachel Shalini
Journal:  J Clin Diagn Res       Date:  2013-03-21

Review 10.  Mineralocorticoid receptor antagonism confers cardioprotection in heart failure.

Authors:  Michael R Seawell; Fahed Al Darazi; Victor Farah; Kodangudi B Ramanathan; Kevin P Newman; Syamal K Bhattacharya; Karl T Weber
Journal:  Curr Heart Fail Rep       Date:  2013-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.